Atrial fibrillation (AF) is the most common sustained arrhythmia. Previous studies have identified several genetic loci associated with typical AF. We sought to identify common genetic variants underlying lone AF. This condition affects a subset of individuals without overt heart disease and with an increased heritability of AF. We report a meta-analysis of genome-wide association studies conducted using 1,335 individuals with lone AF (cases) and 12,844 unaffected individuals (referents). Cases were obtained from the German AF Network, Heart and Vascular Health Study, the Atherosclerosis Risk in Communities Study, the Cleveland Clinic and Massachusetts General Hospital. We identified an association on chromosome 1q21 to lone AF (rs13376333, adjusted odds ratio = 1.56; P = 6.3 × 10 −12 ), and we replicated this association in two independent cohorts with lone AF (overall combined odds ratio = 1.52, 95% CI 1.40-1.64; P = 1.83 × 10 −21 ). rs13376333 is intronic to KCNN3, which encodes a potassium channel protein involved in atrial repolarization.
overt structural heart disease, present at a young age and are referred to as having lone AF 1 . Individuals with lone AF are more likely to have symptomatic, paroxysmal episodes than older individuals with more typical forms of AF observed in the community. In many individuals with lone AF, discrete foci of ectopic electrical activity that initiate AF have been found to originate within the pulmonary veins. Although lone AF appears to have a more benign course than typical AF 2 , many symptomatic individuals require treatment with an antiarrhythmic medication, electrical cardioversion, a catheter ablation procedure to electrically isolate the pulmonary veins, or a combination of therapies.
Familial aggregation and early onset are prominent features in subjects with lone AF, and nearly 30% of probands with lone AF have a first-degree relative with the disease 3 . Framingham Heart Study (FHS) investigators observed that the odds of developing AF were three times higher for individuals with at least one parent in whom AF was diagnosed before the age of 75 than in those without a parental history of AF 4 . Similarly, in a large study of Icelanders, the risk of developing AF was increased nearly fivefold if one parent was affected before the age of 60 (ref. 5) .
A genome-wide association study (GWAS) in Icelanders identified a chromosome 4q25 locus that was associated with AF 6 . Within this locus, two noncoding SNPs were independently associated with AF. The SNP most strongly associated with AF, rs2200733, conferred a 1.71-fold increased odds of AF (P = 6.1 × 10 −41 ), and rs10033464 caused a 1.42-fold increased odds of AF (P = 3.1 × 10 −11 ) 6 . More recently, two independent GWAS identified an association on chromosome 16q22 to AF Common variants in KCNN3 are associated with lone atrial fibrillation l e t t e r s cases typically observed in the community 7, 8 . rs2106261 within ZFHX3 was associated to AF with a risk ratio of 1.25 (P = 1.8 × 10 −15 ) 7 .
Using well-defined and carefully phenotyped subsets of individuals with a certain disease can facilitate gene discovery for complex traits, such as AF. Lone AF remains a diagnosis of exclusion (whereby a diagnosis is made by elimination of other reasonable conditions) and a consensus definition has yet to emerge 9 . In the current study, lone AF was defined as AF with an onset before 66 years of age and without a preceding history of a myocardial infarction, heart failure or known left ventricular systolic dysfunction. Because individuals with lone AF show a high heritability of AF and a distinct clinical presentation, we sought to identify the common genetic factors underlying lone AF.
Genome-wide genotyping was available for a total of 1,335 individuals with lone AF and 12,844 referent individuals from five centers ( Table 1 and Online Methods). After application of the SNP exclusion criteria in each study (Supplementary Table 1) , the genomic inflation factor (λ) ranged from 0.98 in Atherosclerosis Risk in Communities Study (ARIC) to 1.17 in the Heart and Vascular Health (HVH) and Cardiovascular Health Studies (CHS), and the overall genome-wide meta-analysis λ was 1.017. We generated a quantile-quantile plot of the expected versus observed P value distributions for associations of the approximately 2.5 million SNPs from individuals with lone AF (Supplementary Fig. 1a) . We also plotted the results of the lone AF meta-analysis with the −log 10 (P value) against physical coordinates on 22 autosomal chromosomes (Fig. 1) . The most significant association with lone AF was at the previously reported 4q25 locus, with 77 SNPs that exceeded our genome-wide significance threshold of P = 5 × 10 −8 . The most significant SNP at this locus was rs6843082 (OR 2.03, 95% CI 1.79-2.30; P = 2.5 × 10 −28 ; Table 2 , Fig. 1, Supplementary  Fig. 2a and Supplementary Table 2) . Given the large number of significant associations at this locus, we produced a modified quantile-quantile plot without the 4q25 SNPS (Supplementary Fig. 1b) .
A second locus identified on chromosome 1q21 had 6 SNPs that exceeded genome-wide significance. The most significant SNP was rs13376333, with an OR of 1.56 (95% CI 1.38-1.77, P = 6.3 × 10 −12 ; Table 2 ). rs13376333 is located in the intron between the first and second exon of the calcium-activated potassium channel gene KCNN3. We created a regional plot of the locus on chromosome 1q21 (Fig. 2) . Our findings at the chromosome 1q21 locus were replicated in two studies of lone AF. First, in 977 cases from the German Competence Network on Atrial Fibrillation (AFNET) and 3,042 controls without AF from Cooperative Health Research in the Region of Augsburg (KORA) S4, rs13376333 was significantly associated with lone AF (OR 1.45, 95% CI 1.26-1.66, P = 8.8 × 10 −8 ). Second, the association was replicated in the Vanderbilt University Lone AF Registry consisting of 187 subjects with lone AF and 565 control subjects without AF (OR 1.55, 95% CI 1.19-2.03, P = 0.001). In a meta-analysis combining the lone AF results from the primary GWAS and the two replication cohorts, rs13376333 had an OR of 1.52 (95% CI 1.40-1.64, P = 1.83 × 10 −21 ).
There was no evidence of an interaction between rs6843082 and rs13376333, the two most significant SNPs at the loci on chromosomes 4q25 and 1q21, respectively (P = 0.46). We also sought to determine whether rs13376333 was associated with more typical forms of AF observed in the community. Using GWAS data from two independent studies in Rotterdam and Reykjavik (Age, Gene/Environment Susceptibility Study or AGES), we found that rs13376333 was associated with typical AF, albeit with a weaker effect (Supplementary Table 3 ) 7 . In a meta-analysis of the associations between this SNP and both incident and prevalent AF in Rotterdam and AGES, rs13376333 had an OR of 1.13 (95% CI 1.04-1.24, P = 0.006).
A third SNP, rs13038095 on chromosome 20q13, also exceeded genome-wide significance (OR 1.61, 95% CI 1.37-1.91, P = 1.1 × 10 −8 ; Table 2 and Supplementary Table 2 ) and is located upstream from SULF2, which encodes endosulfatase (Supplementary Fig. 2b ). However, in the AFNET and Vanderbilt studies, the association of this SNP with AF was in the opposite direction and thus it failed to replicate ( Table 3) . Finally, we confirmed the recent locus for AF on chromosome 16q22 described in a meta-analysis of GWAS data from five longitudinal cohorts with more typical forms of AF observed in the community. The minor allele of rs2106261 was associated with lone AF with an odds ratio of 1.47 (95% CI 1.39-1.54, P = 1.61 × 10 −7 ). 
l e t t e r s
Variants at the 1q21 locus cluster at KCNN3 (also known as SK3 and KCa2.3), which codes for a member of a family of voltageindependent calcium-activated potassium channels. These small conductance channels are expressed in a number of excitable tissues including the brain 10 and heart 11, 12 . In neurons, these channels underlie the classical afterhyperpolarization or inward potassium current that is activated by elevations in calcium following repetitive action-potential stimulation. The role of these channels in the heart is less clear. In a rabbit burst-pacing model designed to simulate pulmonary venous ectopy, pharmacologic blockade of KCNN channels inhibited pacing-induced shortening of pulmonary venous and atrial action potential duration 13 . Shortening of the atrial action potential duration reduces the refractory period of atrial myocytes and promotes re-entry, an important mechanism for the development and maintenance of AF 14 . Although no change was observed in KCNN3 expression in response to burst pacing 13 , expression of a closely related family member, KCNN2, was increased. Differential expression of Kcnn2 in a mouse model is associated with altered pacemaker-cell action-potential duration and spontaneous firing rate 15 . KCNN3 and KCNN2 co-assemble in heteromultimeric channel complexes in vitro 16 ; therefore, genetic variation in either subunit may modulate channel function. However, we did not identify any SNPs within 60 kb of KCNN2 that were significantly associated with lone AF (defined as P < 0.001, data not shown). The KCNN channels also are expressed in vascular endothelial cells, and suppression of Kcnn3 expression in a mouse model has been associated with increased blood pressure 17 . The most significant SNP at this locus, rs13376333, is not in linkage disequilibrium (LD) with any known common, nonsynonymous SNP in KCNN3 18 . Thus, the mechanism by which variation at this locus increases AF risk is unknown. Although KCNN3 is a plausible candidate gene for lone AF, additional studies on the role of this channel and other genes at this locus are warranted. Future work directed at determining the role of the SNPs identified for lone AF in predicting the progression from paroxysmal to permanent AF, or in defining subtypes of lone AF, will be of interest. Furthermore, the utility of KCNN3 as a potential direct or indirect target for the pharmacological treatment of AF may also merit further investigation.
To minimize false positive associations that may arise from GWAS, we used a conservative threshold for genome-wide significance and independently replicated our findings in additional subjects with lone AF. To avoid the confounding influence of population stratification, our analyses were restricted to subjects of European ancestry, so the generalizability of our findings to individuals of non-European ancestry may be limited. Additionally, we included subjects with hypertension in our analysis both because of the high lifetime risk of hypertension and also to maximize the power of our study. However, it is unlikely that hypertension confounded our results because rs13376333 was not associated with systolic or diastolic blood pressure in the Global BPgen Consortium, a metaanalysis of genome-wide association data for blood pressure in over 34,000 individuals from 13 cohorts of European descent (systolic blood pressure +0.2 mm Hg per minor allele, 95% CI −0.1 to +0.5, P = 0.27 and diastolic blood pressure +0.1 mm Hg per minor allele, 95% CI −0.1 to +0.3, P = 0.25) 19 . Further, our results were replicated in individuals from the Vanderbilt study with lone AF in the absence of hypertension. Although we were not able to perform a multivariate analysis adjusting for other associated risk factors for AF, rs1337633 was not associated with body mass index or left atrial size, two other common risk factors for AF (data not shown). Because lone AF is a diagnosis of exclusion, there were variations in the enrollment procedures between sites. In particular, an echocardiogram was not performed on subjects in the ARIC study or on approximately 30% of the subjects in the HVH study. Nevertheless, the identified association at KCNN3 remained consistently replicated in independent populations with lone AF. Finally, the associations we observed do not necessarily imply that the candidate genes discussed are directly involved in the pathogenesis of AF. The associated SNPs may lie within or serve as proxies for noncoding regulatory elements that may affect gene expression at considerable distances from their respective genomic locations.
In summary, we identified a new locus for lone AF at the calcium activated potassium channel gene, KCNN3. Future studies will seek to determine the mechanistic links between genetic variation at this locus and AF. 
